Global Inflammatory Bowel Disease Market 2015-2019 - PowerPoint PPT Presentation

About This Presentation
Title:

Global Inflammatory Bowel Disease Market 2015-2019

Description:

The inflammation in Crohn's disease affects various areas of the GI tract such as the large intestine and small intestine, or both. Inflammatory bowel disease is a chronic medical condition, which has no permanent cure and demands a lifetime of treatment and management. The preferred treatment options include anti-inflammatory steroidal products and immuno-suppressive agents such as the TNF-α inhibitors. Analysts forecast the Global Inflammatory Bowel Disease market to grow at a CAGR of 3.95 percent over the period 2014-2019. Read more details at: – PowerPoint PPT presentation

Number of Views:51

less

Transcript and Presenter's Notes

Title: Global Inflammatory Bowel Disease Market 2015-2019


1
Top 10 Diabetes Care Technologies, Devices and
Therapeutics Markets - Growth, Global Share,
Industry Overview, Analysis, Trends Opportunities
and Forecast 2012 - 2020
Global Inflammatory Bowel Disease Market
2015-2019
2
Description
Report Overview
About Inflammatory Bowel Disease Inflammatory
bowel disease is a condition includes a group of
autoimmune diseases such as Crohn's disease and
ulcerative colitis. It causes chronic
inflammation of a specific part or the entire GI
tract. Both Crohn's disease and ulcerative
colitis include symptoms such as severe
persistent diarrhea, abdominal cramps and pain,
rectal bleeding, fatigue, and weight loss.
Inflammatory bowel disease can also prove to be
life-threatening for the patients. Ulcerative
colitis generally affects the colon, where
inflammation and ulcers develop in the innermost
lining of the colon and the rectum of a patient.
Crohn's disease causes inflammation of the lining
of the GI tract. The inflammation in Crohn's
disease affects various areas of the GI tract
such as the large intestine and small intestine,
or both. Inflammatory bowel disease is a chronic
medical condition, which has no permanent cure
and demands a lifetime of treatment and
management Analysts forecast the Global
Inflammatory Bowel Disease market to grow at a
CAGR of 3.95 percent over the period
2014-2019. Read more details at
http//www.bigmarketresearch.com/global-inflammato
ry-bowel-disease-2015-2019-market
_at_Bigmarketresearch
3
Description
Report Overview
Covered in this Report This report covers the
present scenario and the growth prospects of the
Global Inflammatory Bowel Disease market for the
period 2015-2019. To calculate the market size,
the report considers revenue generated from the
sales of various drugs used in the treatment of
inflammatory bowel disease. The market includes
data from the sales of various drusg which are
used for the treatment of Crohn's Disease and
Ulcerative Colitis. On the basis of the
functioning of the drugs used for treatment, the
Global Inflammatory Bowel Disease market is
categorized into three segments. 5-ASA
Antibiotics Immunomodulators
_at_Bigmarketresearch
4
Key Benefits
Description
On the basis of route of administration adopted
for the treatment, the Global Inflammatory Bowel
Disease market is categorized into two
segments. Oral Parenteral On the basis of
the form of drug used to treat the disease, the
Global Inflammatory Bowel Disease market is
categorized into two segments. Solid
Liquid The report also presents the vendor
landscape and a corresponding detailed analysis
of the top vendors in the Global Inflammatory
Bowel Disease market. The vendor landscape
includes an analysis of the major vendors, along
with the competitive performances of their
portfolios. In addition, the report discusses the
major drivers, challenges and trends influencing
the market. In addition, late-stage pipeline
molecules developed for the treatment of
inflammatory bowel disease are discussed.
_at_Bigmarketresearch
5
Description
Global Inflammatory Bowel Disease Market
2015-2019, has been prepared based on an in-depth
market analysis with inputs from industry
experts. The report covers the Americas, and the
APAC and EMEA regions it also covers the
landscape of the Global Inflammatory Bowel
Disease market and its growth prospects in the
coming years. The report also includes a
discussion of the key vendors operating in this
market. Key Regions Americas APAC EMEA
Key Vendors Abbvie Biogen Idec Janssen
Pharmaceuticals Merck Company Shire UCB
_at_Bigmarketresearch
6
Description
Market Driver Increase in Instances of
Inflammatory Bowel Disease For a full, detailed
list, view our report Market Challenge High
Cost of Drugs For a full, detailed list, view
our report Market Trend Dominance of Market by
Biologics For a full, detailed list, view our
report Enquire About Report _at_ http//www.bigmarke
tresearch.com/report-enquiry/221010
_at_Bigmarketresearch
7
Table Of Contents
Table Of Content
01. Executive Summary 02. List of
Abbreviations 03. Scope of the Report 04. Market
Research Methodology 05. Introduction 06. Disease
Overview Crohn's Disease 07. Disease Overview
Ulcerative Colitis 08. Pipeline Portfolio 09.
Market Landscape 10. Market Segmentation by Type
of Disease 11. Global Crohn's Disease Market 12.
Global Ulcerative Colitis Market 13. Market
Segmentation by Drug Class 14. Market
Segmentation by Type of Molecules 15. Market
Segmentation by Dosage Form 16. Market
Segmentation by Route of Administration 17.
Geographical Segmentation 18. Key Leading
Countries 19. Buying Criteria 20. Market Growth
Drivers 21. Drivers and their Impact 22. Market
Challenges 23. Impact of Drivers and
Challenges 24. Market Trends 25. Trends and their
Impact 26. Vendor Landscape 27. Key Vendor
Analysis 28. Other Reports in this Series
_at_Bigmarketresearch
8
Get Full Information At http//www.bigmarketrese
arch.com/global-inflammatory-bowel-disease-2015-20
19-market
Write a Comment
User Comments (0)
About PowerShow.com